Zio AT ECG Monitoring System vs Cardiomo

Zio AT emphasizes a patient-centric design, being smaller, lighter, and thinner for comfortable and discreet wear, leading to high patient compliance (99%). It is waterproof, allowing for showering and exercise, and requires no battery changes or charging during its 14-day wear. Cardiomo also offers a wearable patch and mobile app, with a battery life of up to 7-10 days and waterproof capabilities, but lacks the same level of documented patient compliance and specific design enhancements for comfort.

Zio AT is an FDA-cleared system with a deep-learned AI algorithm clinically proven to be as accurate as expert cardiologists in detecting 13 types of arrhythmias. It provides continuous, uninterrupted ECG recording for up to 14 days, with comprehensive end-of-wear reports that have 99% physician agreement. Cardiomo also uses AI for disease detection and real-time alerts, and has received ISO 13485 certification, but specific clinical validation studies demonstrating comparable accuracy to Zio AT or expert cardiologists are not as prominently detailed.

Both Tool A (Zio AT) and Tool B (Cardiomo) do not publicly disclose their current pricing, requiring direct contact for details. Zio AT's cost is typically between $1,000 and $2,500, depending on factors like provider and insurance, with financial assistance and installment plans available. Cardiomo previously offered pricing at $200 with a $10 monthly subscription, but current details are not available. Without transparent and current pricing for both, it's difficult to definitively assess which offers better value, as both rely on a 'contact for pricing' model.

Zio AT demonstrates strong enterprise readiness through its established EHR integrations with major systems like Epic, Cerner, Athenahealth, Meditech, and eClinicalWorks, simplifying data collection and workflow efficiency for healthcare providers. It also has a dedicated clinician portal (ZioSuite) and mobile app for patient management and report interpretation. While Cardiomo mentions HIPAA-compliant cloud analytics and a mobile application, it does not detail specific EHR integrations or a comprehensive clinician portal, suggesting a potentially less mature enterprise offering.

Zio AT leverages an FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection, which is a significant innovation in cardiac monitoring. The system offers continuous, uninterrupted ECG recording for up to 14 days, and its patient-centric design has led to high compliance and improved data collection. Cardiomo also utilizes AI for disease detection and offers continuous vital sign monitoring, including fall detection, which is innovative. However, Zio AT's specific FDA clearance for its AI algorithm and its proven accuracy against expert cardiologists give it an edge in documented innovation within the clinical context.

iRhythm provides extensive support and documentation for Zio AT, including a clinical reference manual, detailed instructions for use, patient education resources, and a dedicated customer care line. The MyZio app also offers symptom logging, educational content, and reminders for patients. While Cardiomo offers a mobile application and mentions a user manual, the breadth and accessibility of its support and documentation are not as clearly articulated or as comprehensive as Zio AT's.